The Als Therapy Development Instituteals Tdiis A Nonprofit Biotechnology Organization Focused On Als Research And Treatment Developmentfounded In 1999 In Cambridgemassachusettsit Is The Largest Organization Of Its Kinddedicated To Accelerating Drug Discovery And Clinical Solutions For Amyotrophic Lateral Sclerosisthe Institute Employs Over 30 Scientists And Collaborates With Pharmaceutical Companiesbiotechsand Academic Institutions Worldwide Als Tdi Operates A Comprehensive Drug Discovery Pipelinehaving Evaluated Over 500 Drug Candidatesit Launched The Als Research Collaborative In 2023 To Gather Data And Biological Samples From Als Patientsand Introduced The Als Trial Navigator In 2024 To Assist Patients In Finding Suitable Clinical Trialsthe Organization Is Also Known For Developing Tegoprubartthe First Nonprofit Invented Als Treatment To Reach Clinical Trialsfunding Comes From Donations And Eventswith A Commitment To Directing 87Of Funds Raised To Research Initiatives
